Annual EBIT
-$259.30 M
-$121.90 M-88.72%
December 1, 2023
Summary
- As of February 7, 2025, MYGN annual earnings before interest & taxes is -$259.30 million, with the most recent change of -$121.90 million (-88.72%) on December 1, 2023.
- During the last 3 years, MYGN annual EBIT has fallen by -$171.00 million (-193.66%).
- MYGN annual EBIT is now -194.50% below its all-time high of $274.40 million, reached on June 30, 2014.
Performance
MYGN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$20.40 M
+$16.00 M+43.96%
September 1, 2024
Summary
- As of February 7, 2025, MYGN quarterly earnings before interest & taxes is -$20.40 million, with the most recent change of +$16.00 million (+43.96%) on September 1, 2024.
- Over the past year, MYGN quarterly EBIT has increased by +$5.00 million (+19.69%).
- MYGN quarterly EBIT is now -122.73% below its all-time high of $89.74 million, reached on June 30, 2008.
Performance
MYGN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$113.60 M
+$39.80 M+25.95%
September 1, 2024
Summary
- As of February 7, 2025, MYGN TTM earnings before interest & taxes is -$113.60 million, with the most recent change of +$39.80 million (+25.95%) on September 1, 2024.
- Over the past year, MYGN TTM EBIT has increased by +$119.00 million (+51.16%).
- MYGN TTM EBIT is now -139.21% below its all-time high of $289.74 million, reached on December 31, 2013.
Performance
MYGN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MYGN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.7% | +19.7% | +51.2% |
| 3 y3 years | -193.7% | +60.2% | +17.3% |
| 5 y5 years | -2260.8% | -129.2% | -331.9% |
MYGN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -413.5% | at low | -17.9% | +82.3% | -286.4% | +59.3% |
| 5 y | 5-year | -2260.8% | at low | -149.9% | +84.2% | -1414.7% | +59.3% |
| alltime | all time | -194.5% | at low | -122.7% | +84.2% | -139.2% | +59.3% |
Myriad Genetics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.40 M(-44.0%) | -$113.60 M(-25.9%) |
| Jun 2024 | - | -$36.40 M(+43.3%) | -$153.40 M(-34.0%) |
| Mar 2024 | - | -$25.40 M(-19.1%) | -$232.60 M(-10.3%) |
| Dec 2023 | -$259.30 M(+88.7%) | -$31.40 M(-47.8%) | -$259.30 M(-7.1%) |
| Sep 2023 | - | -$60.20 M(-47.9%) | -$279.10 M(+6.4%) |
| Jun 2023 | - | -$115.60 M(+121.9%) | -$262.30 M(+59.9%) |
| Mar 2023 | - | -$52.10 M(+1.8%) | -$164.00 M(+19.4%) |
| Dec 2022 | -$137.40 M(+172.1%) | -$51.20 M(+18.0%) | -$137.40 M(+6.3%) |
| Sep 2022 | - | -$43.40 M(+150.9%) | -$129.20 M(+187.8%) |
| Jun 2022 | - | -$17.30 M(-32.2%) | -$44.90 M(+52.7%) |
| Mar 2022 | - | -$25.50 M(-40.7%) | -$29.40 M(-41.8%) |
| Dec 2021 | -$50.50 M(-42.8%) | -$43.00 M(-205.1%) | -$50.50 M(+573.3%) |
| Sep 2021 | - | $40.90 M(-2372.2%) | -$7.50 M(-91.6%) |
| Jun 2021 | - | -$1.80 M(-96.1%) | -$89.20 M(-37.5%) |
| Mar 2021 | - | -$46.60 M(+14.2%) | -$142.80 M(-38.9%) |
| Dec 2020 | -$88.30 M(-58.4%) | - | - |
| Sep 2020 | - | -$40.80 M(-26.4%) | -$233.90 M(+10.1%) |
| Jun 2020 | -$212.50 M(-1870.8%) | -$55.40 M(-57.0%) | -$212.50 M(+31.5%) |
| Mar 2020 | - | -$128.80 M(+1347.2%) | -$161.60 M(+514.4%) |
| Dec 2019 | - | -$8.90 M(-54.1%) | -$26.30 M(+152.9%) |
| Sep 2019 | - | -$19.40 M(+331.1%) | -$10.40 M(-186.7%) |
| Jun 2019 | $12.00 M(-90.3%) | -$4.50 M(-169.2%) | $12.00 M(-66.3%) |
| Mar 2019 | - | $6.50 M(-7.1%) | $35.60 M(-17.0%) |
| Dec 2018 | - | $7.00 M(+133.3%) | $42.90 M(+1.7%) |
| Sep 2018 | - | $3.00 M(-84.3%) | $42.20 M(-65.8%) |
| Jun 2018 | $123.30 M(+192.2%) | $19.10 M(+38.4%) | $123.30 M(+4.9%) |
| Mar 2018 | - | $13.80 M(+119.0%) | $117.50 M(+3.8%) |
| Dec 2017 | - | $6.30 M(-92.5%) | $113.20 M(-6.9%) |
| Sep 2017 | - | $84.10 M(+532.3%) | $121.60 M(+188.2%) |
| Jun 2017 | $42.20 M(-73.0%) | $13.30 M(+40.0%) | $42.20 M(-20.8%) |
| Mar 2017 | - | $9.50 M(-35.4%) | $53.30 M(-38.7%) |
| Dec 2016 | - | $14.70 M(+212.8%) | $86.90 M(-25.9%) |
| Sep 2016 | - | $4.70 M(-80.7%) | $117.30 M(-24.8%) |
| Jun 2016 | $156.30 M(+15.7%) | $24.40 M(-43.4%) | $155.90 M(-7.5%) |
| Mar 2016 | - | $43.10 M(-4.4%) | $168.60 M(+4.6%) |
| Dec 2015 | - | $45.10 M(+4.2%) | $161.20 M(+5.8%) |
| Sep 2015 | - | $43.30 M(+16.7%) | $152.40 M(+12.9%) |
| Jun 2015 | $135.10 M(-50.8%) | $37.10 M(+3.9%) | $135.00 M(-10.7%) |
| Mar 2015 | - | $35.70 M(-1.7%) | $151.11 M(-11.5%) |
| Dec 2014 | - | $36.30 M(+40.2%) | $170.70 M(-21.5%) |
| Sep 2014 | - | $25.90 M(-51.3%) | $217.40 M(-20.8%) |
| Jun 2014 | $274.40 M(+20.4%) | $53.21 M(-3.8%) | $274.40 M(-4.4%) |
| Mar 2014 | - | $55.29 M(-33.4%) | $287.10 M(-0.9%) |
| Dec 2013 | - | $83.00 M(+0.1%) | $289.74 M(+10.5%) |
| Sep 2013 | - | $82.90 M(+25.8%) | $262.32 M(+15.1%) |
| Jun 2013 | $228.00 M(+26.4%) | $65.91 M(+13.8%) | $228.00 M(+8.9%) |
| Mar 2013 | - | $57.92 M(+4.2%) | $209.37 M(+6.0%) |
| Dec 2012 | - | $55.59 M(+14.4%) | $197.55 M(+5.4%) |
| Sep 2012 | - | $48.58 M(+2.7%) | $187.43 M(+3.9%) |
| Jun 2012 | $180.32 M(+14.3%) | $47.29 M(+2.6%) | $180.32 M(+3.2%) |
| Mar 2012 | - | $46.10 M(+1.4%) | $174.81 M(+2.5%) |
| Dec 2011 | - | $45.47 M(+9.6%) | $170.54 M(+4.2%) |
| Sep 2011 | - | $41.47 M(-0.7%) | $163.66 M(+3.7%) |
| Jun 2011 | $157.78 M(+16.8%) | $41.78 M(-0.1%) | $157.78 M(+2.7%) |
| Mar 2011 | - | $41.82 M(+8.4%) | $153.62 M(+5.9%) |
| Dec 2010 | - | $38.59 M(+8.4%) | $145.02 M(+2.9%) |
| Sep 2010 | - | $35.59 M(-5.4%) | $140.95 M(+4.4%) |
| Jun 2010 | $135.07 M | $37.62 M(+13.2%) | $135.07 M(+2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $33.23 M(-3.8%) | $131.95 M(-1.5%) |
| Dec 2009 | - | $34.52 M(+16.2%) | $133.99 M(+0.9%) |
| Sep 2009 | - | $29.71 M(-13.9%) | $132.78 M(+14.1%) |
| Jun 2009 | $126.46 M(+105.3%) | $34.49 M(-2.2%) | $116.38 M(-32.2%) |
| Mar 2009 | - | $35.26 M(+5.8%) | $171.63 M(+33.5%) |
| Dec 2008 | - | $33.32 M(+150.3%) | $128.55 M(+48.6%) |
| Sep 2008 | - | $13.31 M(-85.2%) | $86.50 M(+40.4%) |
| Jun 2008 | $61.60 M(-229.1%) | $89.74 M(-1248.1%) | $61.60 M(-252.5%) |
| Mar 2008 | - | -$7.82 M(-10.5%) | -$40.40 M(-3.1%) |
| Dec 2007 | - | -$8.74 M(-24.6%) | -$41.68 M(+93.2%) |
| Sep 2007 | - | -$11.58 M(-5.6%) | -$21.57 M(-13.7%) |
| Jun 2007 | -$47.73 M(+4.7%) | -$12.27 M(+34.9%) | -$24.99 M(-6.4%) |
| Mar 2007 | - | -$9.09 M(-180.0%) | -$26.70 M(-9.7%) |
| Dec 2006 | - | $11.37 M(-175.8%) | -$29.57 M(-41.5%) |
| Sep 2006 | - | -$15.00 M(+7.3%) | -$50.53 M(+10.9%) |
| Jun 2006 | -$45.59 M(+11.9%) | -$13.98 M(+17.0%) | -$45.59 M(+13.0%) |
| Mar 2006 | - | -$11.95 M(+24.5%) | -$40.35 M(+3.2%) |
| Dec 2005 | - | -$9.60 M(-4.5%) | -$39.10 M(-2.7%) |
| Sep 2005 | - | -$10.05 M(+15.0%) | -$40.18 M(-1.4%) |
| Jun 2005 | -$40.74 M(-4.4%) | -$8.74 M(-18.4%) | -$40.74 M(-5.1%) |
| Mar 2005 | - | -$10.71 M(+0.3%) | -$42.92 M(-1.0%) |
| Dec 2004 | - | -$10.68 M(+0.6%) | -$43.38 M(+0.7%) |
| Sep 2004 | - | -$10.62 M(-2.8%) | -$43.08 M(+1.1%) |
| Jun 2004 | -$42.63 M(+55.9%) | -$10.92 M(-2.2%) | -$42.63 M(+8.2%) |
| Mar 2004 | - | -$11.16 M(+7.5%) | -$39.39 M(+14.7%) |
| Dec 2003 | - | -$10.38 M(+2.1%) | -$34.33 M(+9.2%) |
| Sep 2003 | - | -$10.17 M(+32.5%) | -$31.44 M(+15.0%) |
| Jun 2003 | -$27.35 M(+46.6%) | -$7.67 M(+25.6%) | -$27.35 M(+0.8%) |
| Mar 2003 | - | -$6.11 M(-18.4%) | -$27.14 M(+6.6%) |
| Dec 2002 | - | -$7.49 M(+23.3%) | -$25.47 M(+17.0%) |
| Sep 2002 | - | -$6.07 M(-18.7%) | -$21.76 M(+16.6%) |
| Jun 2002 | -$18.66 M(+42.0%) | -$7.47 M(+68.1%) | -$18.66 M(+27.4%) |
| Mar 2002 | - | -$4.44 M(+17.4%) | -$14.65 M(+8.8%) |
| Dec 2001 | - | -$3.78 M(+27.5%) | -$13.46 M(+4.5%) |
| Sep 2001 | - | -$2.97 M(-14.1%) | -$12.88 M(-1.9%) |
| Jun 2001 | -$13.14 M(+13.8%) | -$3.45 M(+6.0%) | -$13.14 M(-0.4%) |
| Mar 2001 | - | -$3.26 M(+1.7%) | -$13.19 M(+1.8%) |
| Dec 2000 | - | -$3.20 M(-0.5%) | -$12.95 M(+7.5%) |
| Sep 2000 | - | -$3.22 M(-8.1%) | -$12.05 M(+4.5%) |
| Jun 2000 | -$11.55 M(-6.9%) | -$3.51 M(+15.9%) | -$11.53 M(+4.9%) |
| Mar 2000 | - | -$3.02 M(+31.4%) | -$10.99 M(+3.6%) |
| Dec 1999 | - | -$2.30 M(-14.8%) | -$10.61 M(-10.9%) |
| Sep 1999 | - | -$2.70 M(-9.1%) | -$11.91 M(-5.6%) |
| Jun 1999 | -$12.40 M(-4.6%) | -$2.97 M(+12.6%) | -$12.61 M(-6.2%) |
| Mar 1999 | - | -$2.64 M(-26.7%) | -$13.44 M(-6.0%) |
| Dec 1998 | - | -$3.60 M(+5.9%) | -$14.30 M(+3.6%) |
| Sep 1998 | - | -$3.40 M(-10.5%) | -$13.80 M(+5.3%) |
| Jun 1998 | -$13.00 M(+4.0%) | -$3.80 M(+8.6%) | -$13.10 M(+33.7%) |
| Mar 1998 | - | -$3.50 M(+12.9%) | -$9.80 M(-4.9%) |
| Dec 1997 | - | -$3.10 M(+14.8%) | -$10.30 M(-10.4%) |
| Sep 1997 | - | -$2.70 M(+440.0%) | -$11.50 M(-8.0%) |
| Jun 1997 | -$12.50 M(+40.4%) | -$500.00 K(-87.5%) | -$12.50 M(-16.1%) |
| Mar 1997 | - | -$4.00 M(-7.0%) | -$14.90 M(+9.6%) |
| Dec 1996 | - | -$4.30 M(+16.2%) | -$13.60 M(+21.4%) |
| Sep 1996 | - | -$3.70 M(+27.6%) | -$11.20 M(+72.3%) |
| Jun 1996 | -$8.90 M | -$2.90 M(+7.4%) | -$6.50 M(+80.6%) |
| Mar 1996 | - | -$2.70 M(+42.1%) | -$3.60 M(+300.0%) |
| Dec 1995 | - | -$1.90 M(-290.0%) | -$900.00 K(-190.0%) |
| Sep 1995 | - | $1.00 M | $1.00 M |
FAQ
- What is Myriad Genetics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Myriad Genetics?
- What is Myriad Genetics annual EBIT year-on-year change?
- What is Myriad Genetics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Myriad Genetics?
- What is Myriad Genetics quarterly EBIT year-on-year change?
- What is Myriad Genetics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Myriad Genetics?
- What is Myriad Genetics TTM EBIT year-on-year change?
What is Myriad Genetics annual earnings before interest & taxes?
The current annual EBIT of MYGN is -$259.30 M
What is the all time high annual EBIT for Myriad Genetics?
Myriad Genetics all-time high annual earnings before interest & taxes is $274.40 M
What is Myriad Genetics annual EBIT year-on-year change?
Over the past year, MYGN annual earnings before interest & taxes has changed by -$121.90 M (-88.72%)
What is Myriad Genetics quarterly earnings before interest & taxes?
The current quarterly EBIT of MYGN is -$20.40 M
What is the all time high quarterly EBIT for Myriad Genetics?
Myriad Genetics all-time high quarterly earnings before interest & taxes is $89.74 M
What is Myriad Genetics quarterly EBIT year-on-year change?
Over the past year, MYGN quarterly earnings before interest & taxes has changed by +$5.00 M (+19.69%)
What is Myriad Genetics TTM earnings before interest & taxes?
The current TTM EBIT of MYGN is -$113.60 M
What is the all time high TTM EBIT for Myriad Genetics?
Myriad Genetics all-time high TTM earnings before interest & taxes is $289.74 M
What is Myriad Genetics TTM EBIT year-on-year change?
Over the past year, MYGN TTM earnings before interest & taxes has changed by +$119.00 M (+51.16%)